The Effect of Metoprolol during Rewarming on the Incidence of Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting

Document Type : Original Article (s)

10.22122/jims.v39i617.13776

Abstract

Background: Atrial fibrillation is one of the most common arrhythmia in heart surgery. The aim of this study was to evaluate the effect of metoprolol injection during rewarming on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.
Methods: This study was performed as a double-blind clinical trial in the cardiac operating room and intensive care unit (ICU) in Chamran hospital, Isfahan, Iran, in patients undergoing non-emergency coronary artery bypass graft surgery. Patients were randomly divided into two groups of 43 patients as case and control groups. The metoprolol group received 10 mg intra-oxygenator metoprolol in rewarming period of cardiopulmonary bypass (CPB), and the case group received 10 cc placebo at the same time. Both groups were monitored during and after surgery.
Findings: The frequency of patients with atrial fibrillation was 25% and 4.7% in the control and intervention groups, respectively. The mean duration of ICU hospitalization was 2.98 and 2.24 days in the control and intervention groups, respectively, with significant difference (P < 0.050). The need to inotrope or antiarrhythmic drugs and shock therapy did not show significant difference between the groups (P > 0.050).
Conclusion: According to our findings, it seems that metoprolol injection during coronary artery bypass grafting can significantly reduce the frequency of atrial fibrillation and the length of ICU stay.

Keywords

References

Lukkarinen H, Hentinen M. Treatments of coronary artery disease improve quality of life in the long term. Nurs Res 2006; 55(1): 26-33.
Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's heart disease e-book: A textbook of cardiovascular medicine. Philadelphia, PA: Elsevier Saunders; 2011.
Jakobsen CJ, Bille S, Ahlburg P, Rybro L, Hjortholm K, Andresen EB. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 1997; 11(6): 746-51.
Kimball TH, Monte E, Fischer M, Mahajan A, Vondriska TM. Differentially methylated CpGs identify patients at risk of post-operative atrial Fibrillation after cardiopulmonary bypass. Circulation 2016; 134(Suppl 1): A19954.
Perrier S, Meyer N, Hoang MT, Announe T, Bentz J, Billaud P, et al. Predictors of atrial fibrillation after coronary artery bypass grafting: a bayesian analysis. Ann Thorac Surg 2017; 103(1): 92-7.
Demircan C, Cikriklar HI, Engindeniz Z, Cebicci H, Atar N, Guler V, et al. Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Emerg Med J 2005; 22(6): 411-4.
Shantsila E, Watson T, Lip GY. Atrial fibrillation post-cardiac surgery: Changing perspectives. Curr Med Res Opin 2006; 22(8): 1437-41.
Dave S, Nirgude A, Gujjar P, Sharma R. Incidence and risk factors for development of atrial fibrillation after cardiac surgery under cardiopulmonary bypass. Indian J Anaesth 2018; 62(11): 887-91.
Halonen J, Hakala T, Auvinen T, Karjalainen J, Turpeinen A, Uusaro A, et al. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrillation after cardiac surgery. Circulation 2006; 114(1 Suppl): I1-I4.
Katzung BG, Masters SB, Trevor AJ. Basic and clinical pharmacology. 13th ed. New York, NY: McGraw-Hill Education; 2015.
Ryden L, Ariniego R, Arnman K, Herlitz J, Hjalmarson A, Holmberg S, et al. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med 1983; 308(11): 614-8.
Omorphos S, Hanif M, Dunning J. Are prophylactic beta-blockers of benefit in reducing the incidence of AF following coronary bypass surgery? Interact Cardiovasc Thorac Surg 2004; 3(4): 641-6.
Ramos F. Is sotalol a better choice over metoprolol for atrial fibrillation prophylaxis post coronary artery bypass graft surgery? [Thesis]. Forest Grove, OR: School of Physician Assistant Studies, Pacific University; 2021.
Lucio EA, Flores A, Blacher C, Leaes PE, Lucchese FA, Ribeiro JP. Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery. Arq Bras Cardiol 2004; 82(1): 42-1.
Benfield P, Clissold SP, Brogden RN. Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders. Drugs 1986; 31(5): 376-429.
Kamali A, Hosseini A, Sharifi M, Pazuki S. A comparative study of the effect of metoral and magnesium prophylactic in controlling atrial fibrillation after coronary arteries bypass operation. Biomedical Research 2017; 28(19): 8449-53.
Zi J, Fan Y, Dong C, Zhao Y, Li D, Tan Q. Anxiety administrated by dexmedetomidine to prevent new-onset of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass graft. Int Heart J 2020; 61(2): 263-72.
Skiba MA, Pick AW, Chaudhuri K, Bailey M, Krum H, Kwa LJ, et al. Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol. Heart Lung Circ 2013; 22(8): 627-33.
Candan S, Pirat A, Aldemir D, Sezgin A, Turkoglu S, Arslan G. Myocardial protective effects of metoprolol and diltiazem given during cardiopulmonary bypass: A-191. Eur J Anaesth 2004; 21(Suppl 32): 48.
Journal of Isfahan Medical School
Volume 39, Issue 617
2021
Pages 174-180

Files

History

  • Receive Date: 01 April 2022
  • Accept Date: 01 April 2022

Share

How to cite

Statistics